Yoder Stephen S. 4
4 · PIERIS PHARMACEUTICALS, INC. · Filed Feb 26, 2018
Insider Transaction Report
Form 4
Yoder Stephen S.
DirectorChief Executive Officer
Transactions
- Award
Stock Options (Right to buy)
[F1]2018-02-20+325,000→ 325,000 totalExercise: $8.56Exp: 2028-02-20→ Common Stock (325,000 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the option shares on January 1, 2019 and vests as to an additional 6.25% of the option shares at the end of each successive three-month period thereafter.
Signature
/s/ Marc D. Mantell, Attorney-in-fact|2018-02-26